Advertisements



Atossa Genetics completes enrollment for Phase 2 study of Topical Endoxifen

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 11th, 2018

Atossa completes all dosing, clinical visits in topical Endoxifen Phase 1 study

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 20th, 2018

Atossa Genetics opens Phase 2 study of topical endoxifen to treat MBD

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 26th, 2018

Atossa Genetics opens enrollment in Phase 2 study of oral Endoxifen

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJul 13th, 2018

Atossa Genetics (ATOS) CEO Steve Quay on Preliminary Results from Male Phase 1 Study of Topical Endoxifen Conference (Transcript)

Atossa Genetics (ATOS) CEO Steve Quay on Preliminary Results from Male Phase 1 Study of Topical Endoxifen Conference (Transcript).....»»

Category: topSource: seekingalphaSep 13th, 2018

Atossa Genetics reports final results from Phase 1 Endoxifen study in males

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJan 9th, 2019

XBiotech completes enrollment in Phase 1 bermekimab study

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 2nd, 2019

Corbus Pharmaceuticals completes enrollment of RESOLVE-1 Phase 3 study

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 2nd, 2019

Mallinckrodt completes enrollment in Phase 4 Acthar Gel study

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallApr 23rd, 2019

Seattle Genetics completes enrollment in pivotal innovaTV 204 phase 2 trial

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMar 29th, 2019

Neurotrope completes enrollment of Phase 2 study of Bryostatin-1

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMar 13th, 2019

VBI Vaccines completes enrollment in PROTECT Phase 3 clinical study

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallApr 19th, 2018

Cardiome completes enrollment for Phase 4 SPECTRUM study

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallApr 17th, 2018

EyeGate completes enrollment for Phase 3 clinical study of EGP-437

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallApr 6th, 2018

Atossa Genetics receives "positive" interim safety review on Endoxifen study

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 15th, 2018

MediWound completes enrollment in NexoBrid U.S. Phase 3 DETECT study

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 11th, 2018

Opko Health completes enrollment in Phase 2b study of OPK88003

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 11th, 2018

Arrowhead completes enrollment in Phase 1 ARO-AAT study in liver disease

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 18th, 2018

Eiger BioPharmaceuticals completes enrollment in Phase 2 PREVENT study

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallAug 13th, 2018

Alnylam completes enrollment in ENVISION Phase 3 study of givosiran

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallAug 21st, 2018

Alnylam Completes Enrollment in Phase III Givosiran Study

Alnylam Pharmaceuticals (ALNY) completes enrollment in the phase III ENVISION study ahead of schedule of its pipeline candidate, givosiran. Alnylam Pharmaceuticals.....»»

Category: smallbizSource: nytAug 22nd, 2018